Global Defibrillators Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Defibrillators market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Defibrillators market."
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The ICDs segment is expected to account for the largest share of the global market in 2017. Factors such as the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the globe are contributing to the large share of this segment.

The global Defibrillators market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 3.1% during 2019-2025.
This report focuses on Defibrillators volume and value at global level, regional level and company level. From a global perspective, this report represents overall Defibrillators market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Medtronic 
    St. Jude Medical 
    Boston Scientific 
    Philips 
    Zoll Medical 
    Biotronik 
    Physio-Control 
    Cardiac Science 
    Livanova 
    Nihon Kohden 
    Schiller 
    Mindray Medical 
    Mediana 
    Metrax 
    Metsis Medikal

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Implantable Cardioverter Defibrillators (ICDs)
    External Defibrillators

Segment by Application
    Hospitals, Clinics, and Cardiac Centers
    Pre-Hospital Care Settings
    Public Access Markets
    Home Care Settings
    Alternate Care Facilities